MSCI ACWI IMI Biotech Advance Index
The MSCI ACWI IMI Biotech Advance Index aims to represent the performance of a set of companies across large, mid and small cap representation across Developed Markets (DM) and Emerging Markets (EM) countries, that are associated with research, development, and commercialization of products for treating a broad range of diseases and disorders.
Data as of March 31, 2025